| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/26/2008 | US7335736 Compositions and methods for detecting Treponema palidum |
| 02/26/2008 | US7335730 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 02/26/2008 | US7335729 PRO4320 polypeptide |
| 02/26/2008 | US7335724 Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis |
| 02/26/2008 | US7335636 SPRR1A and axonal regeneration |
| 02/26/2008 | US7335516 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 02/26/2008 | US7335499 tRNA synthetase |
| 02/26/2008 | US7335482 Method using neutral amino acid transporter expressing cell |
| 02/26/2008 | US7335473 Causative agent of the Mystery Swine Disease, vaccine compositions and diagnostic kits |
| 02/26/2008 | US7335362 Methods of treating pre-eclampsia or eclampsia |
| 02/26/2008 | US7335359 Glycosylated specificity exchangers |
| 02/26/2008 | US7335358 Methods of treating psoriasis with anti-TNF antibodies |
| 02/26/2008 | US7335356 Comprises two heavy chains and two light chains, each chain comprising a variable region and a constant region; vaccines for prevention and diagnosis of viral diseases |
| 02/26/2008 | US7335353 Porcine cells comprising an adenovirus E3 gene region |
| 02/26/2008 | US7335351 Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme |
| 02/26/2008 | CA2369590C Sodium/proton antiporter gene |
| 02/26/2008 | CA2351722C Mast cell-specific signal transducer and cdna thereof |
| 02/26/2008 | CA2315241C Protein rim2 |
| 02/21/2008 | WO2008022295A2 Prlr-specific antibody and uses thereof |
| 02/21/2008 | WO2008022146A2 Polymer-surfactant nanoparticles for sustained release of compounds |
| 02/21/2008 | WO2008021543A2 Transgenic plants with enhanced agronomic traits |
| 02/21/2008 | WO2008021263A2 Methods of indentifying antibodies that bind oligomeric forms of chemokines and uses thereof |
| 02/21/2008 | WO2008021156A2 Antibodies to il-17a |
| 02/21/2008 | WO2008020827A2 Altered polypeptides, immunoconjugates thereof, and methods related thereto |
| 02/21/2008 | WO2008020596A2 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 02/21/2008 | WO2008020108A1 Peptides which are immunogenic in relation to the genuses listeria and mycobacterium, antibodies and uses of these |
| 02/21/2008 | WO2008020079A1 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling |
| 02/21/2008 | WO2007148095A3 Methods for determining a prognosis of colorectal cancer |
| 02/21/2008 | WO2007138143A3 Alpha anticholine kinase monoclonal antibodies and their use in analytical techniques for the diagnosis of cancer and the preparation of medicinal products |
| 02/21/2008 | WO2007128496A3 A group of esterases for the enantioselective production of fine and speciality chemicals |
| 02/21/2008 | WO2007109221A3 Methods for reducing protein aggregation |
| 02/21/2008 | WO2007103523A3 Antioxidant protein, compositions, and methods of use |
| 02/21/2008 | WO2007089563A3 Rabbit monoclonal antibodies against mouse/human id3 proteins |
| 02/21/2008 | WO2007011941A9 Human anti-b7rp1 neutralizing antibodies |
| 02/21/2008 | WO2006053439A9 Hcv f protein and uses thereof |
| 02/21/2008 | WO2006047298A3 Eph receptor tumor biomarkers |
| 02/21/2008 | WO2005060641A3 Engineered templates and their use in single primer amplification |
| 02/21/2008 | US20080047037 the polypeptides have increased activity and stability at acidic, neutral and alkaline pH and increased temperature; for producing an alcohol, high-maltose or a high-glucose syrup or a mixed syrup, for liquifying a starch-comprising composition |
| 02/21/2008 | US20080045926 Treatment of Conditions Involving Dopaminergic Neuronal Degeneration Using Nogo Receptor Antagonists |
| 02/21/2008 | US20080045701 Human Monoclonal Antibody Having Fat-Reducing Effect |
| 02/21/2008 | US20080045700 Canine CD20 Compositions |
| 02/21/2008 | US20080045699 Interleukin-1 Related Gene and Protein |
| 02/21/2008 | US20080045698 Mammalian receptor proteins; related reagents and methods |
| 02/21/2008 | US20080045608 Gene Encoding a Guanine Nucleotide Exchange Factor Binding to Rhoa |
| 02/21/2008 | US20080045499 Preferential Inhibition of Presenilin-1 |
| 02/21/2008 | US20080045456 Use of wild type angiogenin |
| 02/21/2008 | US20080045454 Polynucleotide encoding a TRIM-cyp polypeptide, compositions thereof, and methods of using same |
| 02/21/2008 | US20080045451 Novel thymidylate synthase mutants |
| 02/21/2008 | US20080045444 Compositions and methods for treating cardiovascular disease and myocardial infarction with dipeptidyl peptidase inhibitors or b type natriuretic peptide analogues resistant to prolyl-specific dipeptidyl degradation |
| 02/21/2008 | US20080045443 Compositions for Inhibiting plexin-A1-DAP12 interactions and Methods of Treating Inflammatory, Autoimmune or Bone Resorption Diseases Using the Same |
| 02/21/2008 | US20080044896 Novel human secreted proteins and polynucleotides encoding the same |
| 02/21/2008 | US20080044886 orthogonal pairs of tRNAs and aminoacyl-tRNA synthetases that can incorporate the coumarin unnatural amino acid L-(7-hydroxycoumarin-4-yl) ethylglycine into proteins produced in eubacterial host cells such as E. coli; producing proteins containing the unnatural amino acid |
| 02/21/2008 | US20080044859 Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof |
| 02/21/2008 | US20080044840 Using transmembrane protein with EGF-like and 2 follistatin-like domains 2 (TMEFF2) specific immunogllobulin for diagnosis and treatment of prostate cancer |
| 02/21/2008 | US20080044837 antibody that binds to the extracellular portion of the human Programmed Death-1 (PD-1) receptor at a membrane proximal region; identifying a modulator of CD28 |
| 02/21/2008 | US20080044835 Mammalian chemokine reagents |
| 02/21/2008 | US20080044828 CUDR as biomarker for cancer progression and therapeutic response |
| 02/21/2008 | US20080044820 La1 - the genome of a lactobacillus strain |
| 02/21/2008 | US20080044807 Method of Detecting Hepatitis C Virus |
| 02/21/2008 | US20080044806 diagnostic method and vaccine using a composition comprising truncated r47 protein and truncated r56 protein; reducing HIV viral loads |
| 02/21/2008 | US20080044463 Bradykinin B2 Receptor Antagonist Peptide From Amphibian Skin |
| 02/21/2008 | US20080044431 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms |
| 02/21/2008 | US20080044429 Fc.gamma.RIIB-Specific Antibodies and Methods of Use Thereof |
| 02/21/2008 | US20080044427 Plant virus |
| 02/21/2008 | US20080044426 Novel Atypical Pneumonia-Causing Virus |
| 02/21/2008 | US20080044425 Polypeptides having phospholipase a2 activity |
| 02/21/2008 | US20080044424 Antagonists of protease activated receptor-1 (par1) |
| 02/21/2008 | US20080044423 Compounds |
| 02/21/2008 | US20080044422 CNGH0010 Specific Polynucleotides, Polypeptides, Antibodies, Compositions, Methods and Uses |
| 02/21/2008 | US20080044420 Anti-IL-13 antibodies, compositions, methods and uses |
| 02/21/2008 | US20080044419 Treatment of T Cell Mediated Diseases by Inhibition of Fgfr3 |
| 02/21/2008 | US20080044418 Tumor Antigens and Uses Thereof |
| 02/21/2008 | US20080044417 Cancer, autoimmune and inflammatory disease, vaccines; binds to the extracellular domain of native human Fc gamma RIIB with greater affinity than to the extracellular domain of native human Fc gamma RIIA |
| 02/21/2008 | US20080044415 Hepatocyte growth factor receptor antagonists and uses thereof |
| 02/21/2008 | US20080044414 IL-1beta binding antibodies and fragments thereof |
| 02/21/2008 | US20080044413 EphA2 BiTE molecules and uses thereof |
| 02/21/2008 | US20080044412 Single-Domain Antibody Strengthening Fusion Protein Vh-Ldp-Ae |
| 02/21/2008 | US20080044411 Human glp-1 mimetibodies, compositions, methods and uses |
| 02/21/2008 | US20080044410 Immunoglobulin against growth differentiation factor -8 (GDF-8) for use in the prevention and treatment of bone, muscular, nervous system and obesity; muscle enhancement; disorders of insulin metabolism |
| 02/21/2008 | US20080044409 Inflammatory mediator antagonists |
| 02/21/2008 | US20080044408 Diagnosis, therapy of cancerous diseases; using cancerous disease modifying antibodies |
| 02/21/2008 | US20080044406 Neuroactive fragments of APP |
| 02/21/2008 | US20080044403 Immune Markers Used for Diagnosis and Therapy in Connection With Transplant Reactions |
| 02/21/2008 | US20080044356 Assemblies of Oligomeric Amyloid Beta Protein and Uses Thereof |
| 02/21/2008 | US20080044349 Therapeutic and diagnostic applications of perlecan domain I splice variants |
| 02/21/2008 | US20080040972 Transgenic expression; chimera; herbicide resistance, insect resistance; disease resistance; cells, seeds |
| 02/21/2008 | CA2697742A1 Methods and compositions for treatment and diagnosis of autoimmune encephalitis or epilepsy |
| 02/21/2008 | CA2666599A1 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling |
| 02/21/2008 | CA2661023A1 Prlr-specific antibody and uses thereof |
| 02/21/2008 | CA2660516A1 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 02/21/2008 | CA2660463A1 Antibodies to il-17a |
| 02/21/2008 | CA2658557A1 Optimized antibodies that target cd19 |
| 02/20/2008 | EP1890150A1 Determination of agonistic autoantibodies associated with humoral kidney rejection |
| 02/20/2008 | EP1889915A1 APO-2 ligand |
| 02/20/2008 | EP1889909A1 Improvement of disease resistance of plant by introducing transcription factor gene |
| 02/20/2008 | EP1889908A1 Anti-cd14 antibody-fused protein |
| 02/20/2008 | EP1889631A1 Cell growth inhibition |
| 02/20/2008 | EP1889060A2 Monoclonal antibody reagents |
| 02/20/2008 | EP1888649A2 Antigen binding molecules having modified fc regions and altered binding to fc receptors |
| 02/20/2008 | EP1888648A2 Methods of treating, diagnosing or detecting cancer |